Source: Citybizlist

Expansion Therapeutics: Expansion Therapeutics Announces Key Additions to Scientific Advisory Board

BOSTON-(BUSINESS WIRE)-Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the... Read MoreThe post Expansion Therapeutics Announces Key Additions to Scientific Advisory Board appeared first on citybiz.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Renato Skerlj's photo - President & CEO of Expansion Therapeutics

President & CEO

Renato Skerlj

CEO Approval Rating

90/100

Read more